Clinical Therapeutics II (PAS 223) is the second course of a 4-part series focused on pharmacology and clinical therapeutics. The pharmacology component will focus on mechanism of action, clinical use, contraindications, adverse reactions, and clinically significant drug interactions of various drug classes. The clinical therapeutics component will focus on medical management of diseases with an emphasis on patient specific drug management. Discipline-specific topics include:Pharmacology:- Mechanism of action, clinical use, contraindications, adverse reactions, and clinically significant drug interactions of various drug classes/drugs Clinical Therapeutics:- Disease-state management: Hypertension, hyperlipidemia, asthma, COPD, acute decompensated heart failure, chronic heart failure, ischemic heart disease/stable angina, acute coronary syndrome, arrhythmias, and infectious diseases (fungal, pneumonia)Enrollment limited to MSPA students.
2 units · Medical School MD Grades
Clinical Therapeutics II (PAS 223) is the second course of a 4-part series focused on pharmacology and clinical therapeutics. The pharmacology component will focus on mechanism of action, clinical use, contraindications, adverse reactions, and clinically significant drug interactions of various drug classes. The clinical therapeutics component will focus on medical management of diseases with an emphasis on patient specific drug management. Discipline-specific topics include:Pharmacology:- Mechanism of action, clinical use, contraindications, adverse reactions, and clinically significant drug interactions of various drug classes/drugs Clinical Therapeutics:- Disease-state management: Hypertension, hyperlipidemia, asthma, COPD, acute decompensated heart failure, chronic heart failure, ischemic heart disease/stable angina, acute coronary syndrome, arrhythmias, and infectious diseases (fungal, pneumonia)Enrollment limited to MSPA students.
Offered in Spring 2026 at Stanford University.